NDC 42385-915 – Efavirenz, emtricitabine and tenofovir disoproxil fumarate

Efavirenz 600 mg/1; Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC42385-915

Product details

Brand name
Efavirenz, emtricitabine and tenofovir disoproxil fumarate
Generic name
Efavirenz, emtricitabine and tenofovir disoproxil fumarate
Labeler
Laurus Labs Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA213541
Marketed since
December 22, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Efavirenz, emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (2)

Package NDCDescriptionSince
42385-915-3030 TABLET, FILM COATED in 1 BOTTLE (42385-915-30)Dec 22, 2021
42385-915-9090 TABLET, FILM COATED in 1 BOTTLE (42385-915-90)Dec 22, 2021

Other Efavirenz, emtricitabine and tenofovir disoproxil fumarate products